Medicxi Ventures participates in €18.5 million financing round of Alderaan Biotechnology
Client(s) Medicxi Ventures (UK) LLP
Jones Day advised Medicxi Ventures in connection with the €18.5 million financing round of Alderaan Biotechnology, a company engaged in the research and development of antibodies targeting certain molecules for the treatment of cancer.